Open Access
Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2
Publication type: Journal Article
Publication date: 2021-02-01
scimago Q1
wos Q2
SJR: 1.200
CiteScore: 10.4
Impact factor: 4.4
ISSN: 23194170, 23202890
PubMed ID:
33640332
General Medicine
Abstract
The present outburst of coronavirus-associated (SARS-CoV-2) acute respiratory disease coronavirus disease 19 (COVID-19) in December 2019 in Wuhan, China is the third recognised spill over due to the zoonotic transmission. SARS-CoVs are about 29.7 kb positive, single stranded (ss) RNA viruses that are considered as zoonotic pathogens, bat being their natural reservoirs and also shows transmission within humans. The rapidly increasing COVID-19 cases and need of best and efficient drug/vaccine/strategy to counteract the virus entry and its pathogenesis has made it a Herculean challenge for scientists. Synthetic drugs associated complications has attracted scientific attention for natural product-based drugs. Chemo-diversity of algae and cyanobacteria offers a novel approach and can be recognized as a relevant source for developing a future natural “antiviral drug”. The aim of this review is to highlight important features of SARS-CoV-2/COVID-19 and the antiviral compounds recognized in algae and cyanobacteria, with their mechanisms of actions. Algae possess both immunity improving capacity and suppresses many viruses. Thus, they can be recommended as a preventive and curative remedy against SARS-CoV-2.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
|
|
|
Marine Drugs
4 publications, 10%
|
|
|
3 Biotech
2 publications, 5%
|
|
|
Algal Research
2 publications, 5%
|
|
|
Natural Product Reports
1 publication, 2.5%
|
|
|
International Journal of Molecular Sciences
1 publication, 2.5%
|
|
|
Plants
1 publication, 2.5%
|
|
|
Environmental Science and Pollution Research
1 publication, 2.5%
|
|
|
Archives of Microbiology
1 publication, 2.5%
|
|
|
International Journal of Biological Macromolecules
1 publication, 2.5%
|
|
|
Biomedical Journal
1 publication, 2.5%
|
|
|
Bioresource Technology
1 publication, 2.5%
|
|
|
Chronic Diseases and Translational Medicine
1 publication, 2.5%
|
|
|
Microorganisms
1 publication, 2.5%
|
|
|
Polymers
1 publication, 2.5%
|
|
|
Journal of Biomolecular Structure and Dynamics
1 publication, 2.5%
|
|
|
Current Research in Nutrition and Food Science
1 publication, 2.5%
|
|
|
Antibiotiki i Khimioterapiya
1 publication, 2.5%
|
|
|
Journal of Medical Virology
1 publication, 2.5%
|
|
|
Frontiers in Microbiology
1 publication, 2.5%
|
|
|
ChemBioChem
1 publication, 2.5%
|
|
|
Mendeleev Communications
1 publication, 2.5%
|
|
|
Experimental and Therapeutic Medicine
1 publication, 2.5%
|
|
|
Brazilian Journal of Microbiology
1 publication, 2.5%
|
|
|
Materials Today Sustainability
1 publication, 2.5%
|
|
|
Studies in Natural Products Chemistry
1 publication, 2.5%
|
|
|
Molecules
1 publication, 2.5%
|
|
|
Medicine (United States)
1 publication, 2.5%
|
|
|
Journal of Functional Foods
1 publication, 2.5%
|
|
|
Phytochemistry Reviews
1 publication, 2.5%
|
|
|
1
2
3
4
|
Publishers
|
2
4
6
8
10
12
|
|
|
Elsevier
11 publications, 27.5%
|
|
|
MDPI
9 publications, 22.5%
|
|
|
Springer Nature
6 publications, 15%
|
|
|
Wiley
3 publications, 7.5%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 2.5%
|
|
|
Taylor & Francis
1 publication, 2.5%
|
|
|
Enviro Research Publishers
1 publication, 2.5%
|
|
|
Publishing House OKI
1 publication, 2.5%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 2.5%
|
|
|
Frontiers Media S.A.
1 publication, 2.5%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 2.5%
|
|
|
Spandidos Publications
1 publication, 2.5%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 2.5%
|
|
|
IntechOpen
1 publication, 2.5%
|
|
|
Apex Publishing
1 publication, 2.5%
|
|
|
2
4
6
8
10
12
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
40
Total citations:
40
Citations from 2025:
5
(12.5%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Sami N., Ahmad R., Fatma T. Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2 // Biomedical Journal. 2021. Vol. 44. No. 1. pp. 54-62.
GOST all authors (up to 50)
Copy
Sami N., Ahmad R., Fatma T. Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2 // Biomedical Journal. 2021. Vol. 44. No. 1. pp. 54-62.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.bj.2020.11.014
UR - https://doi.org/10.1016/j.bj.2020.11.014
TI - Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2
T2 - Biomedical Journal
AU - Sami, Neha
AU - Ahmad, Rakhshan
AU - Fatma, Tasneem
PY - 2021
DA - 2021/02/01
PB - Elsevier
SP - 54-62
IS - 1
VL - 44
PMID - 33640332
SN - 2319-4170
SN - 2320-2890
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Sami,
author = {Neha Sami and Rakhshan Ahmad and Tasneem Fatma},
title = {Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2},
journal = {Biomedical Journal},
year = {2021},
volume = {44},
publisher = {Elsevier},
month = {feb},
url = {https://doi.org/10.1016/j.bj.2020.11.014},
number = {1},
pages = {54--62},
doi = {10.1016/j.bj.2020.11.014}
}
Cite this
MLA
Copy
Sami, Neha, et al. “Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2.” Biomedical Journal, vol. 44, no. 1, Feb. 2021, pp. 54-62. https://doi.org/10.1016/j.bj.2020.11.014.